Across TCGA pan-cancer cohorts, OR5AC4P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR5AC4P’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where OR5AC4P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR5AC4P is over-expressed in tumor.
BRCA and LUAD are the cancer types where OR5AC4P tumor–normal differential expression is most reproducible.